These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 17101665
1. Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A. Brando C, Ware LA, Freyberger H, Kathcart A, Barbosa A, Cayphas S, Demoitie MA, Mettens P, Heppner DG, Lanar DE. Infect Immun; 2007 Feb; 75(2):838-45. PubMed ID: 17101665 [Abstract] [Full Text] [Related]
2. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Cummings JF, Spring MD, Schwenk RJ, Ockenhouse CF, Kester KE, Polhemus ME, Walsh DS, Yoon IK, Prosperi C, Juompan LY, Lanar DE, Krzych U, Hall BT, Ware LA, Stewart VA, Williams J, Dowler M, Nielsen RK, Hillier CJ, Giersing BK, Dubovsky F, Malkin E, Tucker K, Dubois MC, Cohen JD, Ballou WR, Heppner DG. Vaccine; 2010 Jul 12; 28(31):5135-44. PubMed ID: 19737527 [Abstract] [Full Text] [Related]
3. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. Kester KE, Cummings JF, Ofori-Anyinam O, Ockenhouse CF, Krzych U, Moris P, Schwenk R, Nielsen RA, Debebe Z, Pinelis E, Juompan L, Williams J, Dowler M, Stewart VA, Wirtz RA, Dubois MC, Lievens M, Cohen J, Ballou WR, Heppner DG, RTS,S Vaccine Evaluation Group. J Infect Dis; 2009 Aug 01; 200(3):337-46. PubMed ID: 19569965 [Abstract] [Full Text] [Related]
4. Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A. Stewart VA, McGrath SM, Walsh DS, Davis S, Hess AS, Ware LA, Kester KE, Cummings JF, Burge JR, Voss G, Delchambre M, Garçon N, Tang DB, Cohen JD, Heppner DG. Vaccine; 2006 Oct 30; 24(42-43):6483-92. PubMed ID: 16904798 [Abstract] [Full Text] [Related]
5. Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen. Mettens P, Dubois PM, Demoitié MA, Bayat B, Donner MN, Bourguignon P, Stewart VA, Heppner DG, Garçon N, Cohen J. Vaccine; 2008 Feb 20; 26(8):1072-82. PubMed ID: 18258343 [Abstract] [Full Text] [Related]
9. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes. Wang R, Charoenvit Y, Corradin G, De La Vega P, Franke ED, Hoffman SL. J Immunol; 1996 Nov 01; 157(9):4061-7. PubMed ID: 8892640 [Abstract] [Full Text] [Related]
12. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses. Prieur E, Gilbert SC, Schneider J, Moore AC, Sheu EG, Goonetilleke N, Robson KJ, Hill AV. Proc Natl Acad Sci U S A; 2004 Jan 06; 101(1):290-5. PubMed ID: 14694197 [Abstract] [Full Text] [Related]
13. Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine. Ockenhouse CF, Angov E, Kester KE, Diggs C, Soisson L, Cummings JF, Stewart AV, Palmer DR, Mahajan B, Krzych U, Tornieporth N, Delchambre M, Vanhandenhove M, Ofori-Anyinam O, Cohen J, Lyon JA, Heppner DG, MSP-1 Working Group. Vaccine; 2006 Apr 05; 24(15):3009-17. PubMed ID: 16356603 [Abstract] [Full Text] [Related]
14. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies. Mehrizi AA, Zakeri S, Rafati S, Salmanian AH, Djadid ND. Parasite Immunol; 2011 Nov 05; 33(11):594-608. PubMed ID: 21883290 [Abstract] [Full Text] [Related]
17. Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice. Lumsden JM, Nurmukhambetova S, Klein JH, Sattabongkot J, Bennett JW, Bertholet S, Fox CB, Reed SG, Ockenhouse CF, Howard RF, Polhemus ME, Yadava A. Vaccine; 2012 May 09; 30(22):3311-9. PubMed ID: 22425788 [Abstract] [Full Text] [Related]
18. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa. Dobaño C, Doolan DL. Mol Immunol; 2007 Apr 09; 44(11):3037-48. PubMed ID: 17303242 [Abstract] [Full Text] [Related]
19. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites. Meraldi V, Romero JF, Kensil C, Corradin G. Vaccine; 2005 Apr 15; 23(21):2801-12. PubMed ID: 15780728 [Abstract] [Full Text] [Related]